COST
57
-6
CAT
59
-2
DE
42
3
NAVI
52
-2
ZTS
47
2
THC
60
-5
MCO
71
-7
CPB
22
-5
SLG
57
-3
TXN
43
-5
FFIV
66
-4
HAL
48
-3
TSN
50
-2
UNH
57
-2
SEE
53
3
R
70
-3
KMI
69
-2
INTC
41
4
AMT
37
3
IRM
41
3
COST
57
-6
CAT
59
-2
DE
42
3
NAVI
52
-2
ZTS
47
2
THC
60
-5
MCO
71
-7
CPB
22
-5
SLG
57
-3
TXN
43
-5
FFIV
66
-4
HAL
48
-3
TSN
50
-2
UNH
57
-2
SEE
53
3
R
70
-3
KMI
69
-2
INTC
41
4
AMT
37
3
IRM
41
3
Financhill
Back

Palisades Goldcorp Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
56

PALI.V
Palisades Goldcorp

Last Price:
1.71
Seasonality Move:
-11.59%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
56
Palisades Goldcorp (PALI.V) is a Buy

Is Palisades Goldcorp a Buy, Sell or Hold?

  • The current Palisades Goldcorp [PALI.V] share price is $1.71. The Score for PALI.V is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PALI.V is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PALI.V Stock Price Chart

What is Palisades Goldcorp's stock price today?

  • The Palisades Goldcorp share price today is $1.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI.V is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PALI.V Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 38.21 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.73 - 1.95) Sell
Bollinger Bands (100): (1.84 - 2.26) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PALI.V Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.76 Sell
20-day SMA: 1.86 Sell
50-day SMA: 1.89 Sell
200-day SMA: 2.14 Sell
8-day EMA: 1.76 Sell
20-day EMA: 1.81 Sell
50-day EMA: 1.9 Sell
200-day EMA: 2.14 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Palisades Goldcorp Earnings Growth & PALI.V Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Palisades Goldcorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):